1
2
#OpenInnovation
3
4
News & Events
OncoMyx Announces Presentation of Preclinical Data for Novel Oncolytic Virotherapy
October 19, 2020
Virtual presentation by Chief Scientific Officer, Leslie L. Sharp, Ph.D., on October 20 at 11:55-12:25 ET. Read more
Imago BioSciences Doses First Patient in Phase 2b Study of Bomedemstat
October 2, 2020
1st patient dosed in clinical trial of bomedemstat for the treatment of essential thrombocythemia. Read more
CNU Sejong Hospital Begins Patient Treatments with MRIdian Linac
September 24, 2020
Brings benefits of MRI-guided radiation therapy closer to home for cancer patients in South Korea. Read more
5
#knowledgebase
6
7
News & Events
OncoMyx Announces Presentation of Preclinical Data for Novel Oncolytic Virotherapy
October 19, 2020
Virtual presentation by Chief Scientific Officer, Leslie L. Sharp, Ph.D., on October 20 at 11:55-12:25 ET. Read more
Imago BioSciences Doses First Patient in Phase 2b Study of Bomedemstat
October 2, 2020
1st patient dosed in clinical trial of bomedemstat for the treatment of essential thrombocythemia. Read more
CNU Sejong Hospital Begins Patient Treatments with MRIdian Linac
September 24, 2020
Brings benefits of MRI-guided radiation therapy closer to home for cancer patients in South Korea. Read more
8
Portfolio Highlights
#PharmaBiotech
11
Our View
10
Our Focus
12
#PRI
22
Medical Technologies
#Portfolio
14
The fight continues,
we remain vigilant.
#NewNormal
#BreakTheChain
#FlattenTheCurve
16
Words from
the CEO
17
Portfolio Highlights
#PharmaBiotech
28
Pharmaceutical Biotech
#Portfolio
15
About Us
34
Biorenewables & Others
#Portfolio
19
WHAT'S TRENDING @ XERAYA
Oncomyx to Present Preclinical Data
20
Our Team
21
23
Portfolio Highlights
#Biorenewables
30
Portfolio Highlights
#MedTech
25
26
ARE YOU
The Next
Big Thing?
Submit
A
Proposal
29
36
Career
#Xeraya
35
37
News & Events
OncoMyx Announces Presentation of Preclinical Data for Novel Oncolytic Virotherapy
October 19, 2020
Virtual presentation by Chief Scientific Officer, Leslie L. Sharp, Ph.D., on October 20 at 11:55-12:25 ET. Read more
Imago BioSciences Doses First Patient in Phase 2b Study of Bomedemstat
October 2, 2020
1st patient dosed in clinical trial of bomedemstat for the treatment of essential thrombocythemia. Read more
CNU Sejong Hospital Begins Patient Treatments with MRIdian Linac
September 24, 2020
Brings benefits of MRI-guided radiation therapy closer to home for cancer patients in South Korea. Read more
32
#agro
33
Portfolio Highlights
#Biorenewables
38
Portfolio Highlights
#MedTech
39
40
Contact Us
41
